Search for inhibitors of cell cycle and development for natural molecular probe

细胞周期抑制剂的寻找及天然分子探针的开发

基本信息

  • 批准号:
    15310148
  • 负责人:
  • 金额:
    $ 9.86万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

In search of new pharmaceutically valuable substances from marine organisms, we have been engaged in chemical studies on the bioactive substances, which was isolated from marine invertebrates on the guidance of new practical bioassay.a)Differentiation inducer against leukemia cells and neuroblastoma1)Long-chain acetylene alcohol (lembehyne A) : Lembehyne A(LB-A), isolated from marine sponge of Haliclona sp., induced neuronal cell differentiation in a neuroblastoma cell line, Neuro 2A. Furthermore, the cell cycle of Neuro 2A cell was found to be specifically blocked at the G1 phase by LB-A. The total synthesis of LB-A was achieved, and the several analogues were synthesized from suitable fatty acids. The structure-activity relationship study revealed that the carbon-chain length and 3R configuration are important for neuritogenic activity. To identify the target protein for LB-A, a radioactive photoaffinity probe was synthesized, and the in situ photoaffinity labeling was succeeded in t … More he detection of a protein of Mr 30 kDa. 2)Sesquiterpene aminoquinone (smenospongine) : A new sesquiterpene aminoquinone, 5-epi-smenospongorine, together with nine known sesquiterpene quinone/phenols, was isolated from the marine sponge Dactylospongia elegans as differentiation-inducing substances to K562 cells into erythroblast. Smenospongine increased hemoglobin production in K562 cells and showed increase of glycophorin A expression. The structure-activity relationship study of these compounds clarified that the quinone skeleton is indispensable and the amino group plays an important role.b)Modulator of multi-drug resistance against anti-tumor drugs (inhibitor of P-gp) :Kendarimide A, a novel modulator of multi-drug resistance(MDR) in tumor cells mediated by P-glycoprotein(P-gp) was isolated from a marine sponge of Haliclona sp. The chemical structure of kendarimide A was characterized to be a linear peptide composed of N-methylpyroglutamic acid (pyroMeGlu), N-methylated eight-membered cysteinyl-cysteine (ox-[MeCys-MeCys]) together with many N-methyl amino acid residues, and the absolute stereostructure was determined by comparison with synthetic model compounds. Less
为了从海洋生物中寻找新的药用价值物质,我们在新的实用生物测定的指导下,对从海洋无脊椎动物中分离出的生物活性物质进行了化学研究。a)针对白血病细胞和神经母细胞瘤的分化诱导剂1)长链乙炔醇(lembehyne A):Lembehyne A(LB-A),从海洋中分离 Haliclona sp. 的海绵诱导神经母细胞瘤细胞系 Neuro 2A 中的神经元细胞分化。此外,发现Neuro 2A细胞的细胞周期被LB-A特异性阻断在G1期。实现了LB-A的全合成,并由合适的脂肪酸合成了几种类似物。结构-活性关系研究表明,碳链长度和3R构型对于神经突活性很重要。为了鉴定LB-A的靶蛋白,合成了放射性光亲和探针,并通过原位光亲和标记成功检测到了Mr 30 kDa的蛋白。 2)倍半萜氨基醌(smenospongorine):从海洋海绵Dactylospongia elegans中分离出一种新的倍半萜氨基醌,5-表-smenospongorine,以及九种已知的倍半萜醌/酚,作为K562细胞向红细胞分化的诱导物质。 Smenospongin 增加 K562 细胞中血红蛋白的产生,并显示血型糖蛋白 A 表达的增加。这些化合物的构效关系研究表明,醌骨架是不可或缺的,氨基起着重要作用。b)抗肿瘤药物多药耐药调节剂(P-gp抑制剂):Kendarimide A是从海洋生物中分离得到的一种新型P-糖蛋白(P-gp)介导的肿瘤细胞多药耐药(MDR)调节剂。 Haliclona sp. 海绵Kendarimide A的化学结构被表征为由N-甲基焦谷氨酸(pyroMeGlu)、N-甲基化八元半胱氨酰-半胱氨酸(ox-[MeCys-MeCys])和许多N-甲基氨基酸残基组成的线性肽,并通过与合成的模型化合物比较确定了其绝对立体结构。较少的

项目成果

期刊论文数量(94)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Komodoquinone A, a novel neuritogenic anthracycline, from marine Streptomyces sp KS3
  • DOI:
    10.1021/np030212k
  • 发表时间:
    2003-10-01
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    Itoh, T;Kinoshita, M;Kobayashi, M
  • 通讯作者:
    Kobayashi, M
Pyridoacridine alkaloids inducing neuronal differentiation in a neuroblastoma cell line, from marine sponge Biemna fortis
  • DOI:
    10.1016/s0968-0896(03)00086-5
  • 发表时间:
    2003-05-01
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Aoki, S;Wei, H;Kobayashi, M
  • 通讯作者:
    Kobayashi, M
「難培養微生物研究の最新技術」海綿由来生理活性物質と共生微生物(工藤俊章, 大熊盛也監修)
“难培养微生物研究的最新技术”来自海绵和共生微生物的生理活性物质(工藤俊明、大隈守矢监修)
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    伊東祐二(他;3名);伊藤卓也
  • 通讯作者:
    伊藤卓也
S.Aoki: "Pyridoacridine alkaloids inducing neuronal differentiation in a neuroblastoma cell line, from marine sponge Biemna fortis"Bioorg.Med.Chem.. 11. 1969-1973 (2003)
S.Aoki:“吡啶吖啶生物碱诱导神经母细胞瘤细胞系中的神经元分化,来自海洋海绵 Biemna fortis”Bioorg.Med.Chem.. 11. 1969-1973 (2003)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Reversal of the resistance to ST1571 in human chronic myelo-genous leukemia K562 cells
人慢性粒细胞白血病K562细胞对ST1571耐药性的逆转
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    伊東祐二(他;6名);M.Mukai
  • 通讯作者:
    M.Mukai
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KOBAYASHI Motomasa其他文献

KOBAYASHI Motomasa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KOBAYASHI Motomasa', 18)}}的其他基金

Creation of novel molecular-targeted anticancer drugs focused on specific phenotypic changes of cells in tumor
开发专注于肿瘤细胞特定表型变化的新型分子靶向抗癌药物
  • 批准号:
    26242074
  • 财政年份:
    2014
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of short-step synthesis of probe molecules for accelerating target identification
开发探针分子的短步合成以加速目标识别
  • 批准号:
    25560402
  • 财政年份:
    2013
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Establishment of in vivo screening system using Medaka fish toward to the drug discovery
建立利用青鳉鱼进行药物发现的体内筛选系统
  • 批准号:
    22659002
  • 财政年份:
    2010
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Investigation of benthonic marine organisms in Indonesia searching for new medicinal seeds.
对印度尼西亚底栖海洋生物进行调查,寻找新的药用种子。
  • 批准号:
    21406002
  • 财政年份:
    2009
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Search for Bioactive Natural Products for Molecular Target Chemotherapy of Cancer
寻找用于癌症分子靶向化疗的生物活性天然产物
  • 批准号:
    18201042
  • 财政年份:
    2006
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Investigation of Indonesian Marine Organisms as Medicinal Resources
印度尼西亚海洋生物作为药用资源的调查
  • 批准号:
    15406005
  • 财政年份:
    2003
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Search for Indonesian Marine Life as Medicinal Resource (2)
寻找印度尼西亚海洋生物作为药用资源 (2)
  • 批准号:
    11691208
  • 财政年份:
    1999
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Search for Reversing Agents of Multidrug-Resistance in Tumor Cells from Marine Organisms
从海洋生物中寻找肿瘤细胞多药耐药性逆转剂
  • 批准号:
    10680567
  • 财政年份:
    1998
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Search for New Anti-tumor Lead Compounds from Marine Organisms
从海洋生物中寻找新的抗肿瘤先导化合物
  • 批准号:
    10557233
  • 财政年份:
    1998
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Search for Indonesian Marine Life as Medicinal Resource
寻找印度尼西亚海洋生物作为药用资源
  • 批准号:
    09041184
  • 财政年份:
    1997
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Grant-in-Aid for international Scientific Research

相似海外基金

Overcoming multi drug resistance in 3D breast cancer cell model by pH-sensitive biomimetic nanoparticles
pH敏感仿生纳米颗粒克服3D乳腺癌细胞模型中的多重耐药性
  • 批准号:
    20K20203
  • 财政年份:
    2020
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
New Multi-Drug Resistance Mechanism in Multiple Myeloma
多发性骨髓瘤多重耐药新机制
  • 批准号:
    10439626
  • 财政年份:
    2020
  • 资助金额:
    $ 9.86万
  • 项目类别:
New Multi-Drug Resistance Mechanism in Multiple Myeloma
多发性骨髓瘤多重耐药新机制
  • 批准号:
    10626002
  • 财政年份:
    2020
  • 资助金额:
    $ 9.86万
  • 项目类别:
New Multi-Drug Resistance Mechanism in Multiple Myeloma
多发性骨髓瘤多重耐药新机制
  • 批准号:
    10029257
  • 财政年份:
    2020
  • 资助金额:
    $ 9.86万
  • 项目类别:
New Multi-Drug Resistance Mechanism in Multiple Myeloma
多发性骨髓瘤多重耐药新机制
  • 批准号:
    10187534
  • 财政年份:
    2020
  • 资助金额:
    $ 9.86万
  • 项目类别:
Investigating multi-drug resistance in lung cancer using metabolomics and cell biology
利用代谢组学和细胞生物学研究肺癌的多药耐药性
  • 批准号:
    2368566
  • 财政年份:
    2020
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Studentship
Predicting evolutionary dynamics of multi-drug resistance
预测多重耐药性的进化动态
  • 批准号:
    MR/R024936/1
  • 财政年份:
    2017
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Fellowship
Strategies overcome Multi-drug resistance in HIV: GAPDH as a restriction factor to suppress the packaging of the primer tRNA for reverse transcription
克服 HIV 多药耐药性的策略:GAPDH 作为限制因子抑制逆转录引物 tRNA 的包装
  • 批准号:
    16K18922
  • 财政年份:
    2016
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
C16-Ceramide Nano-Liposomes Reverse Multi-Drug Resistance
C16-神经酰胺纳米脂质体逆转多药耐药性
  • 批准号:
    9921301
  • 财政年份:
    2016
  • 资助金额:
    $ 9.86万
  • 项目类别:
Understanding the ABCs of multi drug resistance - tying the knot on the antibacterial peptide ABC transporter McjD
了解多重耐药性的ABC - 抗菌肽ABC转运蛋白McjD喜结连理
  • 批准号:
    MR/N020103/1
  • 财政年份:
    2016
  • 资助金额:
    $ 9.86万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了